Collaborative efforts with the Medical University of Vienna resulted in a new manuscript concerning STAT5 activation in CD34+/CD38− MPN stem cells, published in the journal Cancers. The article is a part of the special issue Targeting STAT3 and STAT5 in Cancer.
STAT5 is Expressed in CD34+/CD38– Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Hadzijusufovic E, Keller A, Berger D, Greiner G, Wingelhofer B, Witzeneder N, Ivanov D, Pecnard E, Nivarthi H, Schur FKM, Filik Y, Kornauth C, Neubauer HA, Müllauer L, Tin G, Park J, de Araujo ED, Gunning PT, Hoermann G, Gouilleux F, Kralovics R, Moriggl R, Valent P.
Cancers (Basel). 2020 Apr 21;12(4). pii: E1021. doi: 10.3390/cancers12041021.
Congratulations to all authors involved!
The Moriggl Lab 